Pub. Date : 2007 Apr
PMID : 17374625
9 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Does metronidazole interact with CYP3A substrates by inhibiting their metabolism through this metabolic pathway? | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |
2 | OBJECTIVE: To explore whether CYP3A inhibition by metronidazole is the primary mechanism by which metronidazole interacts with coadministered CYP3A substrates. | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |
3 | OBJECTIVE: To explore whether CYP3A inhibition by metronidazole is the primary mechanism by which metronidazole interacts with coadministered CYP3A substrates. | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |
4 | OBJECTIVE: To explore whether CYP3A inhibition by metronidazole is the primary mechanism by which metronidazole interacts with coadministered CYP3A substrates. | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |
5 | OBJECTIVE: To explore whether CYP3A inhibition by metronidazole is the primary mechanism by which metronidazole interacts with coadministered CYP3A substrates. | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |
6 | DATA SYNTHESIS: Elevated plasma concentrations and toxicities have been reported for a number of CYP3A substrates including amiodarone, carbamazepine, quinidine, tacrolimus, and cyclosporine when administered with metronidazole. | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |
7 | This has led to the widespread belief that metronidazole is a significant inhibitor of CYP3A4. | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |
8 | CONCLUSIONS: Drug interactions between metronidazole and certain CYP3A substrates do not appear to result from CYP3A4/5 inhibition by metronidazole. | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |
9 | Until any mechanism is identified by which metronidazole alters the disposition of certain CYP3A substrates, drug interactions with this agent should be assessed on a case-by-case basis, taking into account the safety index of the coadministered drug and the availability of equally effective substitutes for either metronidazole or the drug with which it putatively interacts. | Metronidazole | cytochrome P450 family 3 subfamily A member 4 | Homo sapiens |